Advertisement

Topics

Latest Endocrinology NewsRSS

21:14 EST 18th January 2017 | BioPortfolio

Eating disorders in middle-aged women 'common'

"Eating disorders…affect a small but substantial number of women in their 40s and 50s," BBC News reports. While often regarded as a "disease of the young", a new survey suggests 3.6% of middle-aged women in the UK are affected by an eating disorder. Researchers also looked at childhood, parenting and personality risk factors associated with the condition. They found that 15% ...

Natural Human Growth Hormone (HGH) Supplements: HGH.com Shares Top 10 Benefits of HGH Releasers

BOONTON, N.J., Jan. 18, 2017 /PRNewswire/ -- Human growth hormone (HGH) has been credited with a variety of positive effects on health and wellness; but since injectable HGH can only legally be prescribed for a limited range of health conditions,* many consumers have turned to natural HGH supplements. HGH.com, an established industry leader that manufactures a range of health and bodybuilding supp...

Aytu BioScience Announces Two Presentations Highlighting Benefits of Natesto® (Testosterone) Nasal Gel in Men at American Urological Association Annual Meeting

ENGLEWOOD, Colo., Jan. 18, 2017 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that two posters demonstrating clinical data for Natesto® (testosterone) Nasal Gel were accepted for presentation at the American Urological Association 2017 Annual Meeting to be ...

The Ranch Treatment Center Welcomes Esteemed Medical Director

Paul Wilhelm Ragan, MD, an award-winning addiction psychiatrist, joins The Ranch treatment center in Tennessee as medical director. Nunnelly, TN (PRWEB) January 18, 2017 The Ranch addiction and mental health treatment center welcomes Paul Wilhelm Ragan, MD, as medical director. Dr. Ragan has over 30 years of experience as a clinician, researcher and presenter. A Diplomate of the American Board of...

PhaseBio Announces $14.7 Million in Convertible Notes to Advance Clinical Development of PB1046 in Orphan Cardiopulmonary Disorders

MALVERN, Pa., Jan. 18, 2017 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing biopolymer-based drugs for the treatment of orphan diseases with an initial focus on cardiopulmonary disorders, today announced the closing of $14.7 million in convertible notes (“Financing”) to advance the clinical development of its lead compound PB1046...

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

LONDON, Jan. 17, 2017 /PRNewswire/ -- This BCC Research report presents a comprehensive look at disorders of the gastrointestinal system and their pharmacological treatment and diagnostic options. Forecast included from 2016 through 2021.Use this report to:- Gain insight into disorders of the gastrointestinal system and their pharmacological treatment and diagnostic options.- Analyze diagnostic op...

Richard R. Smith Joins EMD Serono as Senior Vice President and Head of US Fertility and Endocrinology

ROCKLAND, Mass., Jan. 17, 2017 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that Richard R. Smith has joined the company as Senior Vice President and Head of US Fertility and Endocrinology. In this role, Mr. Smith will oversee the Fertility and Endocrinology businesses in the U.S., including the U.S. Fert...

Versartis Inc VSAR Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryVersartis Inc Versartis is a biopharmaceutical company that develops therapeutic proteins for the treatment of endocrine disorders. The company provides product such as VRS317, a human growth hormone which consists of recombinant human growth hormone and the natural hydrophilic amino acids. Its VRS317 is designed to reduce the burden of daily injection therapy which is used in the treatment...

DiaSorin S.p.A DIA Medical Equipment Deals and Alliances Profile Prices from USD $250

SummaryDiaSorin S.p.A. DiaSorin is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry RIA, Enzyme Linked Immunosorbent Assays ELISA and Chemiluminescence CLIA techniques, to enable automatic diagnostic investigation. The company's products find application in the diagnosis ...

EMD Serono Release: Joins Company As Senior Vice President And Head Of US Fertility And Endocrinology

  Life Sciences Jobs   ...

CMS classifies CGM as ‘durable medical equipment’

The CMS recently announced that continuous glucose monitoring devices will be categorized as “durable medical equipment,” according to a press release from the American Association of Clinical Endocrinologists and the American College of Endocrinology. AACE and ACE are commending the ruling after a 2014 consensus conference on glucose monitoring determined that “glucose monitoring is essenti...

Did You Remember to Take Your Hormone Replacement? The Treatment May Not Help

Women randomized to receive postmenopausal oral estradiol therapy did not show improved memory, executive function, or global cognition, and timing of initiation of hormonal treatment did not affect the outcome.

New Book Reveals How Natural Remedies Can Improve Postpartum Health

Author and naturopathic physician Dr. Nancy Lins, ND shares how lifestyle changes can aid recovery MAUI (PRWEB) January 16, 2017 According to the U.S. Department of Health and Human Services, about 13% of pregnant women and new mothers have depression. Women can experience mood swings, trouble sleeping and a lack of appetite. These indications can be early signs of postpartum depression. Dr. Nanc...

Eating Disorder Hope Announces Winter 2017 Seal of Excellence Recipients

REDMOND, Ore., Jan. 16, 2017 /PRNewswire/ -- Eating Disorder Hope is honored to announce the Winter 2017 recipients of its respected Seal of Excellence. These recipients embody Eating Disorder Hope's message of hope and healing while contributing to the eating disorder community in unique and invaluable ways. Through the Seal of Excellence initiative, Eating Disorder Hope proudly honors d...

OBÉSITÉ : Le test urinaire qui évalue la conformité du régime alimentaire - The Lancet Diabètes and Endocrinology

Nous sommes tous enclins à sous-déclarer la quantité de nourriture que nous consommons, par oubli ou par omission. « Rétablir la vérité » sur l'apport alimentaire réel, apporte 2 avantages majeurs : pour la santé personnelle de chacun de pouvoir suivre l'apport alimentaire réel et pour la recherche, la m...

Nation's veterinarians approve new policy on inherited disorders

CHICAGO, Jan. 14, 2017 /PRNewswire-USNewswire/ -- At its 2017 Winter Session today, the American Veterinary Medical Association (AVMA) House of Delegates (HOD) approved a new policy on inherited disorders in companion animals. The policy reads as follows: Inherited Disorders in Responsible Breeding of Companion Animals To maximize the health and welfare of companion animals, the AVMA sup...

Grünenthal Introduces Latin America’s Most Modern Women’s Health Products Plant

Grünenthal will provide women’s health products for the Latin American market using this new facility Grünenthal invested USD 14.5 million strengthening its position among the three biggest pharmaceutical companies in Chile The new manufacturing site will further enhance Grünenthal’s capabilities in globa...

Researchers pinpoint malfunction on gene linked to ADHD

ADHD is highly genetic, and [the ADGRL3 gene] in particular has long been implicated it its development…Now, a new study goes even further, finding a specific malfunction

SciGen Ltd SIE Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummarySciGen Ltd SciGen, a subsidiary of Bioton SA is a biotechnology company that develops, manufactures and markets recombinant human health care biotechnology derived products. The company's products include recombinant human growth hormone, second generation recombinant human insulin, adjunctive antiepileptic drug, silicone gel, recombinant human granulocytecolony stimulating factor and other...

Millendo Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryMillendo Therapeutics Inc Millendo Therapeutics, formerly Atterocor, Inc., is a pharmaceutical company that focuses on the development of innovative treatments for orphan endocrine disorders such as adrenocortical carcinoma ACC, caused by hormone abnormalities. Its product candidates include MLE4901 and ATR101. The company's MLE4901 is used for the treatment of polycystic ovary syndrome PCO...

JPM17: Opko Health CEO's Gameplan After Its Recent Growth Hormone Failure

  Life Sciences Jobs   ...

Endocrine Society Launches First Open Access Journal

WASHINGTON, Jan. 12, 2017 /PRNewswire-USNewswire/ -- The Endocrine Society unveiled the first issue of its Open Access scholarly publication the Journal of the Endocrine Society (JES) today, marking the first time the Society has introduced a new journal under its ownership in nearly 30 years. The online-only format is specifically intended to rapidly publish emerging science on a variet...

Study Finds ESR1 Mutations Drive Metastasis in ER-Positive Breast Cancer

This video looks at a new study that found that in addition to conferring resistance to hormone therapies, estrogen receptor mutations can cause breast cancer cells to metastasize.

Landmark Study Defines Normal Ranges for Testosterone Levels

New defined reference range can help limit misdiagnoses and unnecessary treatments

Glycogen Storage Disorders GSD Global Clinical Trials Review, H2, 2016 Prices from USD $2500

Glycogen Storage Disorders GSD Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, Glycogen Storage Disorders GSD Global Clinical Trials Review, H2, 2016" provides an overview of Glycogen Storage Disorders GSD clinical trials scenario. This report provides top line data relating to the clinical trials on Glycogen Storage Disorders GSD. Report includes an overview of t...

Quick Search
Advertisement
 

review and buy Endocrinology market research data and corporate reports here